Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
The Incidence and Prognostic Significance of P16 INK4A/ P15 INK4B Gene Alterations in Children With Relapsed ALL Treated on CCG-1941
4 other identifiers
interventional
N/A
3 countries
41
Brief Summary
RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute lymphocytic leukemia and determine the extent of disease. PURPOSE: Diagnostic study to try to detect changes in the genes of children who have been treated for relapsed acute lymphocytic leukemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
41 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1999
CompletedFirst Submitted
Initial submission to the registry
November 1, 1999
CompletedFirst Posted
Study publicly available on registry
May 2, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2006
CompletedAugust 7, 2014
August 1, 2014
7 years
November 1, 1999
August 6, 2014
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (41)
Long Beach Memorial Medical Center
Long Beach, California, 90806, United States
Children's Hospital Los Angeles
Los Angeles, California, 90027-0700, United States
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California, 90095-1781, United States
Children's Hospital of Orange County
Orange, California, 92868, United States
UCSF Cancer Center and Cancer Research Institute
San Francisco, California, 94143-0128, United States
David Grant Medical Center
Travis Air Force Base, California, 94535, United States
Children's Hospital of Denver
Denver, Colorado, 80218, United States
Children's National Medical Center
Washington D.C., District of Columbia, 20010-2970, United States
Shands Hospital and Clinics, University of Florida
Gainesville, Florida, 32610-100277, United States
University of Chicago Cancer Research Center
Chicago, Illinois, 60637-1470, United States
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5289, United States
Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242-1009, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109-0752, United States
CCOP - Kalamazoo
Kalamazoo, Michigan, 49007-3731, United States
University of Minnesota Cancer Center
Minneapolis, Minnesota, 55455, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, 55905, United States
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198-3330, United States
Saint Peter's University Hospital
New Brunswick, New Jersey, 08901-1780, United States
Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
NYU School of Medicine's Kaplan Comprehensive Cancer Center
New York, New York, 10016, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10021, United States
Mount Sinai School of Medicine
New York, New York, 10029, United States
Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
Lineberger Comprehensive Cancer Center, UNC
Chapel Hill, North Carolina, 27599-7295, United States
Veterans Affairs Medical Center - Fargo
Fargo, North Dakota, 58102, United States
CCOP - Merit Care Hospital
Fargo, North Dakota, 58122, United States
Children's Hospital Medical Center - Cincinnati
Cincinnati, Ohio, 45229-3039, United States
Ireland Cancer Center
Cleveland, Ohio, 44106-5065, United States
Children's Hospital of Columbus
Columbus, Ohio, 43205-2696, United States
Doernbecher Children's Hospital
Portland, Oregon, 97201-3098, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838, United States
University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030-4009, United States
Children's Hospital and Regional Medical Center - Seattle
Seattle, Washington, 98105, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109-1024, United States
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, 53792-6164, United States
Princess Margaret Hospital for Children
Perth, Western Australia, 6001, Australia
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3V4, Canada
IWK Health Centre
Halifax, Nova Scotia, B3J 3G9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Stephen P. Hunger, MD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Purpose
- DIAGNOSTIC
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 1999
First Posted
May 2, 2003
Study Start
April 1, 1999
Primary Completion
April 1, 2006
Last Updated
August 7, 2014
Record last verified: 2014-08